2 ms·

This is a good example of how ill-equipped most people are to forming their own opinions about things this complex. The WHO recommends against using remdesivir

This is a good example of how ill-equipped most people are to forming their own opinions about things this complex. The WHO recommends against using remdesivir in hospitalized patients -- which is very different from your claim! The FDA and others make their cutoff point slightly but not substantially later, e.g. remdisivir isn't indicated when a hospitalized patient is on high-flow oxygen. Their disagreement isn't one of substance, just one of scope, and all doctors treating Covid know the rationale behind each cutoff point. But instead any of that nuance, people say things like the "WHO disagrees with FDA" and decide that both are useless so they should take medical advice from morons with podcasts?

beagle3 5y ago
You are arguing against a point I didn't make, and supporting the point I was trying to make. I actually read the papers on remdesivir, and as a result decided that I will not take it if offered, whether hospitalized or not, because of my risk/reward preferences, which may or may not align with the doctor's or the system's. In Israel (where I now reside), AFAIK, they are happily administering it to hospitalized covid patients; at least, they were giving it out a lot until they started treating with regeneron. Now, Israel has its own definition for requiring hospitalization than the WHO or the FDA (e.g. SpO2<94% is considered severe and requiring hospitalization -- if you have a positive PCR test). Do you think the doctors treating covid are actually aware of the minute differences between WHO, FDA, IMOH definitions? I checked with a couple I know. They have no idea.